KTOV

Kitov Pharma Share Price - KTOV

0.815
-0.0058 (-0.71%)
Upgrade to Real-Time
Afterhours (Closed)
0.8208
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Kitov Pharma Ltd KTOV NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0312 -3.66% 0.8208 0.80 0.84 0.8322 0.852 19:54:34
Bid Price Ask Price Spread Spread % News
0.812 0.818 0.006 0.73% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume
18,800 11,844,522  0.8262871  9,786,976 44,120,936
Last Trade Time Type Quantity Stock Price Currency
19:54:34 formt 400  0.815 USD

Kitov Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 129.07M 157.25M 157.25M  1,000.00k  - -0.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News Kitov Pharma

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

KTOV Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Kitov Pharma Ltd is a development stage biopharmaceutical company. It focuses on the development of KIT-302, a combination drug for the simultaneous treatment of two clinical conditions pain caused by osteoarthritis and hypertension; and NT219 which is a fixed-dose combination of two drug products that treat osteoarthritis pain and hypertension simultaneously. The company's operating segment include Pain and Hypertension and Oncology, It generates maximum revenue from the Pain and Hypertension segment.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.